Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Although the deleterious vasoconstrictive effects of cell-free, hemoglobin-based blood substitutes have been appreciated, the systemic effects of chronic hemolysis on nitric oxide bioavailability have not been considered or quantified. Central to this investigation is the understanding that nitric oxide reacts at least 1,000 times more rapidly with free hemoglobin solutions than with erythrocytes. We hypothesized that decompartmentalization of hemoglobin into plasma would divert nitric oxide from homeostatic vascular function. We demonstrate here that plasma from patients with sickle-cell disease contains cell-free ferrous hemoglobin, which stoichiometrically consumes micromolar quantities of nitric oxide and abrogates forearm blood flow responses to nitric oxide donor infusions. Therapies that inactivate plasma hemoglobin by oxidation or nitric oxide ligation restore nitric oxide bioavailability. Decompartmentalization of hemoglobin and subsequent dioxygenation of nitric oxide may explain the vascular complications shared by acute and chronic hemolytic disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Priapism, nephropathy, and sickle vasculopathy are associated with hemolysis.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“In these complications HbF has a less obvious beneficial effect, perhaps because only a small number of lysed sickle erythrocytes are needed to trigger these subphenotypes.59”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“As HbF falls and fewer F-cells are protected from HbS polymer damage, the propensity for vascular occlusion and intravascular hemolysis increases with the release of heme products into the circulation that scavenge nitric oxide causing endothelial damage and vasculopathy.[57][58][59]”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“A further consequence of sickling of cells is increased RBC hemolysis. Hemolysis affects not only the number of circulating RBCs but also release of Hb (and other cytoplasmic proteins) within the blood stream, thus profoundly affecting the viscosity and colloid properties of plasma and increasing systemic NO scavenging (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
In the citing paper
“For example, in hemolytic anemia, release of free Hb may lead to systemic NO scavenging, affecting vascular tone (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
Citations
Cites
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712
Mechanism of NO-induced oxidation of myoglobin and hemoglobin
Eich, R. F., Li, T., Lemon, D. D., Doherty, D. H., Curry, S. R., Aitken, J. F., Mathews, A. J., Johnson, K. A., Smith, R. D., Phillips, et al. (1996) · Biochemistry · doi:10.1021/bi960442g · Cited by 613
Diffusion-limited reaction of free nitric oxide with erythrocytes
Liu, X., Miller, M. J. S., Joshi, M. S., Sadowska-Krowicka, H., Clark, D. A., & Lancaster, J. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18709 · Cited by 512
A Tutorial on the Diffusibility and Reactivity of Free Nitric Oxide
Lancaster, J. R. (1997) · Nitric Oxide · doi:10.1006/niox.1996.0112 · Cited by 495
Nitric oxide in the human respiratory cycle
McMahon, T. J., Moon, R. E., Luschinger, B. P., Carraway, M. S., Stone, A. E., Stolp, B. W., Gow, A. J., Pawloski, J. R., Watke, P., Singel, D. J., et al. (2002) · Nature Medicine · doi:10.1038/nm718 · Cited by 469
Gladwin, M. T., Shelhamer, J. H., Schechter, A. N., Pease-Fye, M. E., Waclawiw, M. A., Panza, J. A., Ognibene, F. P., & Cannon, R. O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11482 · Cited by 441
Self-citationRate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin
Doherty, D. H., Doyle, M. P., Curry, S. R., Vali, R. J., Fattor, T. J., Olson, J. S., & Lemon, D. D. (1998) · Nature Biotechnology · doi:10.1038/nbt0798-672 · Cited by 432
Autoxidation kinetics of aqueous nitric oxide
Ford, P. C., Wink, D. A., & Stanbury, D. M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81748-o · Cited by 419
Research works printed but not linked: 3
- Vaughn, M.W., Kuo, L. & Liao, J.C. Effective diffusion distance of nitric oxide in the microcirculation. Am. J. Physiol. 274, H1705–H1714 (1998).
- Vogel, W.M., Dennis, R.C., Cassidy, G., Apstein, C.S. & Valeri, C.R. Coronary constrictor effect of stroma-free hemoglobin solutions. Am. J. Physiol. 251, H413–H420 (1986).
- Pohl, U. & Lamontagne, D. Impaired tissue perfusion after inhibition of endothelium-derived nitric oxide. Basic Res. Cardiol. 86, 97–105 (1991).
Cited by
Items 501–600 of 1,000
Right Ventricular Systolic Strain Is Altered in Children with Sickle Cell Disease
Blanc, J., Stos, B., de Montalembert, M., Bonnet, D., & Boudjemline, Y. (2012) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2012.01.011 · Cited by 39
Almeida, C. B., Traina, F., Lanaro, C., Canalli, A. A., Saad, S. T. O., Costa, F. F., & Conran, N. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07264.x · Cited by 39
“Nitric oxide bioavailability is reported to be significantly decreased in SCD individuals, as a consequence of its consumption by cell-free haemoglobin (Reiter et al, 2002).”
BackgroundBao, Y., Wang, J., Li, C., Li, P., Wang, S., & Lin, Z. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.02.004 · Cited by 40
New Insights into Paroxysmal Nocturnal Hemoglobinuria
Brodsky, R. A. (2006) · Hematology · doi:10.1182/asheducation-2006.1.24 · Cited by 39
Novelli, E. M., Hildesheim, M., Rosano, C., Vanderpool, R., Simon, M., Kato, G. J., & Gladwin, M. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114309 · Cited by 38
“[4–7] Again, paradoxically, endothelial function studies in humans clearly show that many patients, especially those with higher rates of hemolytic anemia, exhibit impaired response to major endothelial vasodilators, such as nitric oxide.[6, 8, 9] More recent studies have also shown that when an appropriate control po…”
BackgroundSelf-citationKhaleel, M., Puliyel, M. M., Shah, P., Sunwoo, J., Kato, R. M., Chalacheva, P., Thuptimdang, W., Detterich, J. A., Wood, J. C., Tsao, J., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24858 · Cited by 38
Kim‐Campbell, N., Gretchen, C., Callaway, C. W., Felmet, K. A., Kochanek, P. M., Maul, T. M., Wearden, P., Sharma, M., Viegas, M. L., Munoz, R. A., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002703 · Cited by 38
Self-citationVascular complications of sickle cell disease
Usmani, A., & Machado, R. F. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189008 · Cited by 40
“The free hemoglobin also increases vasoconstrictor tone and amplifies NO resistance by inhibiting NO-dependent vasodilators [33].”
Thrombotic Complications in Patients with Immune-Mediated Hemolysis
Capecchi, M., Ciavarella, A., Artoni, A., Abbattista, M., & Martinelli, I. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081764 · Cited by 41
“The release of RBC-derived microvesicles, rich in hemoglobin, may account, owing to NO scavenging, for the enhancement of a prothrombotic state in hemolytic anemia [57].”
BackgroundPremature Atherosclerosis in Children With β-Thalassemia Major
Gürsel, O., Kürekçi, A. E., Taşçılar, E., İleri, T., Altun, D., Tapan, S., Kurt, İ., Kocaoğlu, M., Aydın, A., Okutan, V., et al. (2012) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3182707f4d · Cited by 39
Gaston, B. M., & Hare, J. M. (2003) · New England Journal of Medicine · doi:10.1056/nejm200307243490419 · Cited by 38
Heme Scavenging and Delivery: The Role of Human Serum Albumin
Simone, G. D., Varricchio, R., Ruberto, T. F., di Masi, A., & Ascenzi, P. (2023) · Biomolecules · doi:10.3390/biom13030575 · Cited by 41
Cusack, R. A. F., Bos, L. D. J., Póvoa, P. M. S. R., & Martín‐Loeches, I. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1203827 · Cited by 41
“Cell-free haemoglobin precipitates release of reactive oxygen species (ROS) which impairs the endothelial integrity, leading to vasculopathy (56, 57).”
BackgroundCarbon Quantum Dots with Tunable Size and Fluorescence Intensity for Development of a Nano‐biosensor
Park, S., Tan, J. K. S., Mo, X., Song, Y., Lim, J., Liew, X. R., Chung, H., & Kim, S. (2025) · Small · doi:10.1002/smll.202404524 · Cited by 44
Transfusion of Stored Autologous Blood Does Not Alter Reactive Hyperemia Index in Healthy Volunteers
Berra, L. M., Coppadoro, A., Yu, B., Lei, C., Spagnolli, E., Steinbicker, A. U., Bloch, K. D., Lin, T., Sammy, F., Warren, H. S., et al. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31825575e6 · Cited by 37
“The nitric oxide scavenging activity of plasma hemoglobin is one possible mechanism by which transfusion of 40DS packed erythrocytes could reduce nitric oxide bioavailability, as suggested by the nitric oxide scavenging properties of plasma obtained from patients affected by hemolytic diseases.(27,28) In our study, th…”
BackgroundBelini-Junior, E., da Silva, D. G. H., Torres, L. S., de Almeida, E. A., Cançado, R. D., CHIATTONE, C. S., & Bonini-Domingos, C. R. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1340-y · Cited by 37
“As a result of this process, intravascular haemolysis occurs, and free plasma Hb generates reactive oxygen species (ROS), such as superoxide and hydroxyl radicals [5], which are potent scavengers of nitric oxide (NO) [6], causing vascular endothelium dysfunction [7].”
BackgroundPulmonary and Systemic Vascular Resistances After Cardiopulmonary Bypass: Role of Hemolysis
Rezoagli, E., Ichinose, F., Strelow, S., Roy, N., Shelton, K., Matsumine, R., Chen, L., Bittner, E. A., Bloch, D. B., Zapol, W. M., et al. (2016) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2016.06.009 · Cited by 42
Sarode, R., Ballas, S. K., Garcia, A., Kim, H. C., King, K. E., Sachais, B. S., & Williams, L. A. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21511 · Cited by 38
“When plasma from a patient with SCD is combined in vitro with a solution of nitric oxide, the nitric oxide is consumed in proportion to the amount of heme present in the plasma.(67)”
BackgroundInfluentialWhite matter has impaired resting oxygen delivery in sickle cell patients
Chai, Y., Bush, A., Coloigner, J., Nederveen, A. J., Tamrazi, B., Vu, C. Q., Choi, S., Coates, T. D., Leporé, N., & Wood, J. C. (2019) · American Journal of Hematology · doi:10.1002/ajh.25423 · Cited by 39
“Cell free hemoglobin is metabolized by heme oxygenase, producing free iron and carbon monoxide, a potent cerebral vasodilator.(46,50) In a parallel vascular circuit, excessive vasodilation of one bed could produce ischemia in another.”
BackgroundDecoding the role of SOD2 in sickle cell disease
Dosunmu-Ogunbi, A. M., Wood, K. C., Novelli, E. M., & Straub, A. C. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000527 · Cited by 39
“It also scavenges NO, limiting its bioavailability.(70,72) In the proinflammatory milieu of SCD, sickled RBCs have increased adhesion to the vascular endothelium via vascular adhesion molecule 1, intracellular adhesion molecule 1, E-selectin, and P-selectin.”
BackgroundRecent Advances in Biological and Clinical Aspects of Paroxysmal Nocturnal Hemoglobinuria
Luzzatto, L., & Gianfaldoni, G. (2006) · International Journal of Hematology · doi:10.1532/ijh97.06117 · Cited by 37
Sakamoto, T. M., Lanaro, C., Ozelo, M. C., Garrido, V. T., Saad, S. T. O., Conran, N., & Costa, F. F. (2013) · Microvascular Research · doi:10.1016/j.mvr.2013.10.002 · Cited by 37
Subclinical Atherosclerosis In Young β-thalassemia Major Patients
Tantawy, A. A. G., Adly, A. A. M., Maaty, M. E.-G. A. E., & Amin, S. A. G. (2009) · Hemoglobin · doi:10.3109/03630260903343616 · Cited by 37
Arterial Stiffness and Wave Reflections in Patients With Sickle Cell Disease
Lemogoum, D., Bortel, L. M. V., Najem, B., Dzudié, A., Teutcha, C., Madu, E. C., Leeman, M., Degaute, J.-P., & van de Borne, P. (2004) · Hypertension · doi:10.1161/01.hyp.0000148506.73622.ba · Cited by 41
Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!
Gladwin, M. T., & Kato, G. J. (2007) · Haematologica · doi:10.3324/haematol.12318 · Cited by 41
“ated endothelial dysfunction and vasculopathy.(18-21) During normal physiology, endothelial-derived nitric oxide is pro-”
BackgroundSelf-citationBlood, A. B., Schroeder, H. J., Terry, M. H., Merrill-Henry, J., Bragg, S. L., Vrancken, K., Liu, T., Herring, J. L., Sowers, L. C., Wilson, S. M., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.001073 · Cited by 36
Alfhili, M. A., Weidner, D. A., & Lee, M. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.04.211 · Cited by 36
“Circulating, naked hemoglobin is highly reactive and can participate in oxidative damage manifested as perturbations in endothelial cell function, hypertension, thrombosis, and atherosclerotic lesions (Miller and Shaklai, 1999; Reiter et al., 2002; Studt et al., 2005; Silva et al., 2009).”
BackgroundPal, M., Bao, W., Wang, R., Liu, Y., An, X., Mitchell, W. B., Lobo, C. A., Minniti, C. P., Shi, P. A., Manwani, D. G., et al. (2020) · Blood · doi:10.1182/blood.2020008511 · Cited by 38
Gutsaeva, D. R., Montero-Huerta, P., Parkerson, J. B., Yerigenahally, S. D., Ikuta, T., & Head, C. A. (2014) · Blood · doi:10.1182/blood-2013-06-510180 · Cited by 36
Cryopreserved red blood cells are superior to standard liquid red blood cells
Hampton, D., Wiles, C., Fabricant, L. J., Kiraly, L. N., Differding, J. A., Underwood, S. J., Le, D. T., Watters, J. M., & Schreiber, M. A. (2014) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000268 · Cited by 36
“Previous work investigating NO has shown that increased levels of free hemoglobin secondary to hemolysis resulted in decreased NO levels and a perfusion deficit.(27) Oxygen delivery is also affected by the RBCs’ deformability.”
BackgroundClinical Usefulness of Haptoglobin Levels to Evaluate Hemolysis in Recently Transfused Patients
Gupta, S., Ahern, K. D., Nakhl, F., & Forte, F. J. (2011) · Advances in Hematology · doi:10.1155/2011/389854 · Cited by 36
“Also, there has been considerable interest in the effects of free hemoglobin on nitric oxide and the resulting vascular complications seen in both acute and chronic hemolysis [9, 10] and these findings merit further investigation.”
BackgroundPulmonary hypertension in thalassaemia major patients with normal left ventricular systolic function
Hagar, R. W., Morris, C. R., & Vichinsky, E. P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06053.x · Cited by 40
“For example, high systemic haemolytic rates with their depletion of nitric oxide (Reiter et al, 2002), increase arginase activity (Kaneko et al, 1998) may lead to chronic organ damage (Hebbel et al, 2004) and endothelial dysfunction (Reiter et al, 2002).”
BackgroundZhou, Z., Behymer, M., & Guchhait, P. (2010) · Anemia · doi:10.1155/2011/918916 · Cited by 36
Vaso-occlusion in sickle cell anemia: role of interactions between blood cells and endothelium
Élion, J., Brun, M., Odièvre, M., Lapouméroulie, C., & Krishnamoorthy, R. (2004) · The Hematology Journal · doi:10.1038/sj.thj.6200452 · Cited by 36
Potoka, K. P., Wood, K. C., Baust, J., Bueno, M., Hahn, S. A., Vanderpool, R. R., Bachman, T. N., Mallampalli, G. M., Osei-Hwedieh, D. O., Schrott, V. M., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0292oc · Cited by 36
Self-citationHemolysis and Kidney Injury in Cardiac Surgery: The Protective Role of Nitric Oxide Therapy
Spina, S., Lei, C., Pinciroli, R., & Berra, L. M. (2019) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2019.06.008 · Cited by 38
Aggarwal, S., Lazrak, A., Ahmad, I., Yu, Z., Bryant, A. S., Mobley, J. A., Ford, D. A., & Matalon, S. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101592 · Cited by 35
Nitric Oxide in Cardiac Surgery: A Review Article
Олегович, К. Н., Duong, N., & Berra, L. M. (2023) · Biomedicines · doi:10.3390/biomedicines11041085 · Cited by 38
Gladwin, M. T., Wang, X., & Hogg, N. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.05.025 · Cited by 35
Self-citationChapter 7 Effects of Nitric Oxide on Red Blood Cell Development and Phenotype
Čokić, V. P., & Schechter, A. N. (2008) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(07)00007-5 · Cited by 38
Self-citationVasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction
Nader, É., Conran, N., Romana, M., & Connes, P. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200024 · Cited by 38
Pulmonary Arterial Hypertension: Yesterday, Today, Tomorrow
Michelakis, E. D. (2014) · Circulation Research · doi:10.1161/circresaha.115.301132 · Cited by 36
Li, W., Xu, X., Liu, P., Strouse, J. J., Casella, J. F., Lu, H., van Zijl, P. C. M., & Qin, Q. (2019) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27972 · Cited by 36
Antwi‐Boasiako, C., Andemariam, B., Colombatti, R., Asare, E. V., Strunk, C. J., Piccone, C. M., Manwani, D. G., Boruchov, D., Farooq, F., Urbonya, R., et al. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04057-8 · Cited by 38
Gerogianni, A., Dimitrov, J. D., Zarantonello, A., Poillerat, V., Chonat, S., Sandholm, K., Ekholt, K., Ekdahl, K. N., Mollnes, T. E., Mohlin, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.901876 · Cited by 35
“org 10 anticoagulated plasma in concentrations corresponding to levels found in severe hemolytic conditions (2, 20, 40), impaired C3bdegradation of both soluble and surface-bound C3b.”
BackgroundWorld Health Organization Group 5 Pulmonary Hypertension
Lahm, T., & Chakinala, M. M. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.08.005 · Cited by 35
Liem, R. I., Nevin, M., Prestridge, A. L., Young, L., & Thompson, A. A. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.20996 · Cited by 36
“This is aligned with the current literature in SCD, which has focused on hemolysis and the role that plasma free hemoglobin plays in nitric oxide dysregulation, a potential contributor to PHT.(34) Although other factors may also play a role in the development of TRJVelevation and PHT, we found no significant associati…”
InfluentialEmerging pharmacotherapeutic approaches for the management of sickle cell disease
Torres, L. S., & Conran, N. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1548610 · Cited by 36
“Endothelial cell activation, which occurs as a consequence of endothelium-derived nitric oxide (NO) depletion by cell-free hemoglobin released during hemolysis [21,22], oxidative stress, and constant inflammatory processes [12], plays a key role in the vaso-occlusive process.”
BackgroundClinical hemoglobinopathies: iron, lungs and new blood
Morris, C. R., Singer, S. T., & Walters, M. C. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.moh.0000245685.24462.4e · Cited by 35
Kristiansson, A., Gram, M., Flygare, J., Hansson, S. R., Åkerström, B., & Storry, J. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197234 · Cited by 36
“Since free Hb is a potent scavenger of the vasodilator nitric oxide [118], it possibly contributes to some of the vasoconstriction and hypertension observed in PE.”
BackgroundPotential therapeutic action of nitrite in sickle cell disease
Wajih, N., Basu, S., Jailwala, A., Kim, H. W., Ostrowski, D., Perlegas, A. S., Bolden, C. A., Buechler, N. L., Gladwin, M. T., Caudell, D. L., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.05.006 · Cited by 33
“The concentrations of calcium and ionophores employed here were arrived at based on previous results and empirical attempts to produce measurable changes in deformability that are comparable to those observed in SCD [66] For samples treated with nitrite, after an initial bolus of 10 µM nitrite incubated for 10 min at…”
BackgroundInfluentialSelf-citationSantana, S. S., Pitanga, T. N., de Santana, J. M., Zanette, D. L., Vieira, J. D. J., Yahouédéhou, S. C. M. A., Adanho, C. S. A., Viana, S. D. M., Luz, N. F., Borges, V. M., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01488 · Cited by 34
“Indeed, patients with SCA can present (i) intravascular and extravascular hemolysis with free heme release; (ii) autoxidation of HbS (3, 7); (iii) nitric oxide (NO) depletion and endothelial dysfunction (8, 9); (iv) ischemia-reperfusion events (10); (v) marked leukocyte dysfunction, conferring a non-effector response…”
BackgroundModeling oxidative injury response in human kidney organoids
Przepiorski, A. J., Vanichapol, T., Espiritu, E. B., Crunk, A. E., Parasky, E., McDaniels, M. D., Emlet, D. R., Salisbury, R., Happ, C. L., Vernetti, L. A., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02752-z · Cited by 35
“Intravascular hemolysis occurs in many disease settings such as rhabdomyolysis, sepsis, ischemia reperfusion injury (IRI), sickle cell anemia or cardiac bypass [1, 2].”
BackgroundDysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia
Morris, C. R., Kim, H., Klings, E. S., Wood, J. C., Porter, J. B., Trachtenberg, F. L., Sweeters, N., Olivieri, N. F., Kwiatkowski, J. L., Virzi, L., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13452 · Cited by 33
“In addition, the process of haemolysis disables the arginine-NO pathway through the simultaneous release of erythrocyte-arginase and cell-free haemoglobin, where both NO and its obligate substrate arginine are rapidly consumed (Reiter et al, 2002; Morris et al, 2005a,b, 2007; Morris, 2008).”
BackgroundThe trials and hopes for drug development in sickle cell disease
Ataga, K. I., & Stocker, J. W. (2015) · British Journal of Haematology · doi:10.1111/bjh.13548 · Cited by 33
“With the release of erythrocyte arginase1, which metabolizes plasma arginine into ornithine, haemolysis results in a decrease in the required substrate for NO synthesis and further decreases the bioavailability of NO in patients with SCD (Reiter et al, 2002; Gladwin, 2006).”
BackgroundKim, K., Li, J., Barazia, A., Tseng, A., Youn, S., Abbadessa, G., Yu, Y., Schwartz, B. E., Andrews, R. K., Gordeuk, V. R., et al. (2016) · Haematologica · doi:10.3324/haematol.2016.151159 · Cited by 32
“Oxidative stress results in reduced NO bioavailability in SCD patients and mice, which in turn aggravates inflammatory conditions.(38,39) Hydroxyurea has many beneficial effects in SCD patients.”
BackgroundImmunoregulatory networks in sickle cell alloimmunization
Yazdanbakhsh, K. (2016) · Hematology · doi:10.1182/asheducation-2016.1.457 · Cited by 36
“The chronic hemolytic state of SCD results in substantial release of free hemoglobin and its oxidized form heme in the circulation.(21,22) Free hemoglobin and heme cause pro-oxidant and cytotoxic damage through extravascular translocation; free radical generation and oxidative damage to lipids, proteins, and nucleic a…”
BackgroundTangudu, N. K., Alan, B., Vinchi, F., Wörle, K., Lai, D., Vettorazzi, S., Leopold, K., & Spasić, M. V. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7089 · Cited by 32
Structural insights into heme binding to IL-36α proinflammatory cytokine
Wißbrock, A., Goradia, N., Kumar, A., George, A. A. P., Kühl, T., Bellstedt, P., Ramachandran, R., Hoffmann, P., Galler, K., Popp, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53231-0 · Cited by 34
Musa, H. H., El-Sharief, M., Musa, I. H., Musa, T. H., & Akintunde, T. Y. (2021) · Scientific African · doi:10.1016/j.sciaf.2021.e00774 · Cited by 36
Hemodynamic responses to visual stimulation in children with sickle cell anemia
Zou, P., Helton, K. J., Smeltzer, M. P., Li, C., Conklin, H. M., Gajjar, A. J., Wang, W. C., Ware, R. E., & Ogg, R. J. (2011) · Brain Imaging and Behavior · doi:10.1007/s11682-011-9133-4 · Cited by 32
“With either approach, the detection of activation with fMRI in SCA patients may be compromised by anemia and abnormal cerebral hemodynamics (D’Esposito et al. 2003; Prohovnik et al. 2009; Reiter et al. 2002), even if the neural activity itself was unaffected by disease.”
Fens, M. H. A. M., Larkin, S. K., Oronsky, B. T., Scicinski, J. J., Morris, C. R., & Kuypers, F. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101626 · Cited by 33
“On the one hand this will lead to NO scavenging [44], but since hemolysate is effective in reducing nitrite, this may paradoxically lead to increased NO formation.”
BackgroundMethodReduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin
Nekhai, S., Xu, M., Foster, A., Kasvosve, I., Diaz, S., Machado, R. F., Castro, O. L., Kato, G. J., Taylor, J. G., & Gordeuk, V. R. (2013) · Haematologica · doi:10.3324/haematol.2012.066530 · Cited by 31
“Ferritin (ng/ml)* 9 88 (29-273) 69 211 (74-602) 0.”
Anele, U. A., Mack, A. K., Resar, L. M. S., & Burnett, A. L. “. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0737-7 · Cited by 32
“During hemolysis, free hemoglobin is released, which avidly scavenges intravascular NO, decreasing normal levels [11, 12].”
Möckesch, B., Connes, P., Charlot, K., Skinner, S. C., Hardy‐Dessources, M., Romana, M., Jumet, S., Petras, M., Divialle‐Doumdo, L., Martin, C., et al. (2017) · British Journal of Haematology · doi:10.1111/bjh.14693 · Cited by 34
“Several studies have suggested that increased haemolysis and oxidative stress may play a major role in the development of chronic vasculopathy in SS (Reiter et al, 2002; Morris et al, 2005; Kato et al, 2006, 2007; Nur et al, 2011; Chirico & Pialoux, 2012).”
BackgroundRabbani, N., & Thornalley, P. J. (2008) · Methods in Enzymology · doi:10.1016/s0076-6879(07)00822-1 · Cited by 32
Ghosh, S., Tan, F., Yu, T., Li, Y., Adisa, O. A., Mosunjac, M. I., & Ofori-Acquah, S. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018399 · Cited by 31
“Thus, the plasma of patients with SCD contains excess cellfree hemoglobin and heme [10,12] and is depleted of hemopexin [9].”
BackgroundSickle cell vaso-occlusion: The dialectic between red cells and white cells
Conran, N., & Embury, S. H. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211005392 · Cited by 37
“SRBC have a significantly reduced half-life compared to normal RBC,(23) leading to extravascular and intravascular hemolysis, the latter of which accounts for up to 30% of red cell lysis.(23,47,48) Besides making an important contribution to hemolytic anemia and accelerating erythropoiesis, intravascular hemolysis is…”
BackgroundTeixeira, R., Terse-Ramos, R., Ferreira, T. A., Machado, V. R., Perdiz, M. I., Lyra, I. M., Nascimento, V. M. L., Boa‐Sorte, N., Andrade, B. B., & Ladeia, A. M. T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184076 · Cited by 41
Rat liver-mediated metabolism of hydroxyurea to nitric oxide
Huang, J., Yakubu, M., Kim‐Shapiro, D. B., & King, S. B. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.002 · Cited by 34
Huang, J., Zou, Z., Kim‐Shapiro, D. B., Ballas, S. K., & King, S. B. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0301538 · Cited by 31
New fundamental and applied mechanisms in exercise hemorheology
Connes, P., Suhr, F., Martin, C., Shin, S., Aufradet, É., Sunoo, S., Brixius, K., de Mauverger, É. R., Romana, M., Messonnier, L. A., et al. (2010) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2010-1291 · Cited by 30
Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia
da Guarda, C. C., Santiago, R. P., Fiuza, L. M., Aleluia, M. M., Ferreira, J. R. D., Figueiredo, C. V. B., Yahouédéhou, S. C. M. A., de Oliveira, R. M., Lyra, I. M., & Gonçalves, M. D. S. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1327809 · Cited by 35
“oxidation of cellular membranes have been described in SCA [36,55].”
BackgroundMandal, A. K., Mitra, A., & Das, R. (2020) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-41769-7_12 · Cited by 30
Pathophysiology and treatment of sickle cell disease.
Raphael, R. I. (2005) · PubMed · Cited by 34
Hematopoietic Stem Cell Transplantation for Hemoglobinopathies: Current Practice and Emerging Trends
Smiers, F. J. W., Krishnamurti, L., & Lucarelli, G. (2010) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2010.01.003 · Cited by 32
Ragab, S. M., Safan, M. A., Obeid, O. M., & Sherief, A. S. (2014) · Hematology · doi:10.1179/1607845414y.0000000180 · Cited by 30
Nguyen, V. T., Nassar, D., Batteux, F., Raymond, K., Tharaux, P., & Aractingi, S. (2015) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.11.005 · Cited by 30
Ataga, K. I., Brittain, J. E., Jones, S., May, R., Delaney, J., Strayhorn, D., Desai, P. C., Redding‐Lallinger, R., Key, N. S., & Orringer, E. P. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08410.x · Cited by 31
“Although the pathophysiology of PHT in SCD is probably multifactorial, chronic intravascular haemolysis, with associated destruction of nitric oxide (NO) by cell-free plasma haemoglobin and reactive oxygen species, appears to play a central role (Aslan et al, 2000, 2001; Reiter et al, 2002).”
BackgroundLandburg, P. P., Teerlink, T., Muskiet, F. A. J., Duits, A. J., & Schnog, J. B. (2008) · American Journal of Hematology · doi:10.1002/ajh.21184 · Cited by 30
“During the clinically asymptomatic state NO bioavailability is reduced in sickle cell patients due to the scavenging of NO by cell-free hemoglobin released from hemolyzed sickle erythrocytes [4], as well as due to increased arginase activity [5].”
BackgroundSomanah, J., Bourdon, E., Rondeau, P., Bahorun, T., & Aruoma, O. I. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.11.050 · Cited by 33
The role of hemoglobin in nitric oxide transport in vascular system
Su, H., Liu, X., Du, J., Deng, X., & Fan, Y. (2020) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2020.100034 · Cited by 33
Is there a genetic basis for pediatric stroke?
Kirkham, F. J. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200312000-00002 · Cited by 29
Raat, N. J. H., Tabima, D. M., Specht, P. A. C., Tejero, J., Champion, H. C., Kim‐Shapiro, D. B., Baust, J., Mik, E. G., Hildesheim, M. E., Stasch, J., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5181 · Cited by 30
“Cell-free plasma hemoglobin levels in SCD patients are elevated due to saturation of hemoglobin scavenging systems (haptoglobin), and plasma NO consumption values are much higher than controls (25).”
InfluentialSelf-citationComplement in sickle cell disease and targeted therapy: I know one thing, that I know nothing
Tampaki, A., Gavriilaki, E., Varelas, C., Anagnostopoulos, Α., & Vlachaki, E. (2021) · Blood Reviews · doi:10.1016/j.blre.2021.100805 · Cited by 32
Impaired antioxidant capacity causes a disruption of metabolic homeostasis in sickle erythrocytes
Chaves, N. A., Alegria, T. G. P., Dantas, L. S., Netto, L. E. S., Miyamoto, S., Bonini-Domingos, C. R., & da Silva, D. G. H. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.034 · Cited by 29
Sickle cell disease as a vascular disorder
Ofori-Acquah, S. F. (2020) · Expert Review of Hematology · doi:10.1080/17474086.2020.1758555 · Cited by 30
“vailability is due in part to NO consumption by cell-free Hb [13,14].”
BackgroundEmerging ‘A’ therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginine
Vichinsky, E. P. (2012) · Hematology · doi:10.1182/asheducation.v2012.1.271.3798318 · Cited by 31
Role of Macrophages in Sickle Cell Disease Erythrophagocytosis and Erythropoiesis
Sesti‐Costa, R., Costa, F. F., & Conran, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076333 · Cited by 29
“Nonbound cell-free hemoglobin reacts with vascular nitric oxide (NO), incurring a significant reduction in local NO bioavailability and the generation of (Hb-Fe3+), amongst other products [33,34].”
BackgroundErythrocytes: Member of the immune system that should not be ignored
Ren, Y., Yan, C., & Yang, H. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104039 · Cited by 29
Eculizumab effect on the hemostatic state in patients with paroxysmal nocturnal hemoglobinuria
Seregina, E. A., Tsvetaeva, N. V., Nikulina, O. F., Zapariy, A. P., Erasov, A. V., Грибкова, И. В., Борисовна, О. Е., Ataullakhanov, F. I., & Balandina, A. N. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.11.021 · Cited by 29
The proteome of sickle cell disease: insights from exploratory proteomic profiling
Yuditskaya, S., Suffredini, A. F., & Kato, G. J. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.88 · Cited by 28
Sickle Cell Disease: New Insights into Pathophysiology and Treatment
Inati, A. C., Koussa, S., Taher, A. T., & Perrine, S. P. (2008) · Pediatric Annals · doi:10.3928/00904481-20080501-07 · Cited by 31
Krajewski, M. L., Hsu, L. L.-Y., & Gladwin, M. T. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00499.2008 · Cited by 31
“Unlike coronary artery disease and its risk factors, which are associated with an impaired production of NO, SCD and other hemolytic diseases are characterized by a primary resistance to the action of NO (10, 13, 25, 29).”
BackgroundSelf-citationSickle cell disease and dental treatment.
Piccin, A., Fleming, P., Eakins, E., McGovern, E., Smith, O. P., & McMahon, C. (2008) · PubMed · Cited by 28
Multiple biomarkers of sepsis identified by novel time-lapse proteomics of patient serum
Hayashi, N., Yamaguchi, S., Rodenburg, F. J., Wong, S. Y., Ujimoto, K., Miki, T., & Iba, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222403 · Cited by 30
Bases moléculaires et physiopathologiques des maladies de l'hémoglobine
Labie, D., & Élion, J. (2005) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/j.emch.2005.10.001 · Cited by 30
Swartz, H. M., Mason, R. P., Hogg, N., Kalyanaraman, B., Sarna, T., Plonka, P. M., Zareb, M., Gutiérrez, P. L., & Berliner, L. J. (2005) · Biological magnetic resonance · doi:10.1007/0-387-26741-7_3 · Cited by 29
Self-citationSickle cell microvascular paradox—oxygen supply‐demand mismatch
Detterich, J. A., Kato, R. M., Bush, A., Chalacheva, P., Ponce, D., Zoysa, M. Y. D., Shah, P., Khoo, M. C. K., Meiselman, H. J., Coates, T. D., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25476 · Cited by 27
“Free hemoglobin decreases nitric oxide bioavailability through scavenging in the lumen and scavenging at the basement membrane.(7,59,60) Lastly, FMD is a specific test of shear mediated endothelial nitric oxide production and release when placing the cuff distal to the artery measured.”
BackgroundDetection of nitric oxide production in cell cultures by luciferin–luciferase chemiluminescence
Woldman, Y. Y., Eubank, T. D., Mock, A. J., Stevens, N. C., Varadharaj, S., Turco, J., Gavrilin, M. A., Branchini, B. R., & Khramtsov, V. V. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.001 · Cited by 28
Metadata
- Authors
- Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T.
- Affiliations
- National Institutes of Health (US)
- Medical College of Wisconsin (US)
- Corresponding author
- Gladwin, Mark T.
- Venue
- Nature Medicine
- Published
- 2002-11-11
- Volume
- 8
- Issue
- 12
- Pages
- 1383-1389
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4241694836
- Semantic Scholar
- 80bbf9611dbe14c7276b2a4dbca6e42007866746
- Cited by
- 1,330
- References
- 45
- Citations by year
- 2026: 44 · 2025: 39 · 2024: 45 · 2023: 39 · 2022: 57 · 2021: 55 · 2020: 56 · 2019: 59 · 2018: 60 · 2017: 45 · 2016: 62 · 2015: 63 · 2014: 69 · 2013: 68 · 2012: 68
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM55792)
- National Center for Research Resources (P41RR001008, RR 01008)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- free hemoglobin, nitric oxide bioavailability, sickle cell disease, chronic hemolysis, plasma hemoglobin, forearm blood flow, hemoglobin oxidation, vasoconstriction
- MeSH terms
- Adult, Anemia, Sickle Cell, Biological Availability, Heme, Hemocyanins, Hemoglobins, Hemolysis, Humans, Middle Aged, Nitric Oxide, Oxidation-Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.